In conclusion, UVI5008 was an epigenetic modifier that inhibited HDAC and DNMT, which efficiently induced the selective death of cancer cells and exerted its activity in a genetic mouse breast cancer model and several human tumor xenografts. This evidence concerns the gene HDAC9 and breast cancer.